(Q39646385)

13 September 2017

title

Human αIFN co-formulated with milk derived E2-CSFV protein induce early full protection in vaccinated pigs (English)

1 reference

13 September 2017

Jorge R Toledo

1

1 reference

13 September 2017

Maritza Barrera

2

1 reference

13 September 2017

Omar Farnós

3

1 reference

13 September 2017

Silvia Gómez

4

1 reference

13 September 2017

María P Rodríguez

5

1 reference

13 September 2017

Felix Aguero

6

1 reference

13 September 2017

Valeska Ormazabal

7

1 reference

13 September 2017

Natalie C Parra

8

1 reference

13 September 2017

Lester Suárez

9

1 reference

13 September 2017

Oliberto Sánchez

10

1 reference

13 September 2017

language of work or name

English

0 references

publication date

8 October 2010

1 reference

13 September 2017

1 reference

13 September 2017

volume

28

1 reference

13 September 2017

issue

50

1 reference

13 September 2017

page(s)

7907-7914

1 reference

Introduction to classical swine fever: virus, disease and control policy

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Clinical signs and epidemiology of classical swine fever: a review of new knowledge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Chimeric pestiviruses: candidates for live-attenuated classical swine fever marker vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Highly protective E2-CSFV vaccine candidate produced in the mammary gland of adenoviral transduced goats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Vaccinology of classical swine fever: from lab to field

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Recent advances in the development of recombinant vaccines against classical swine fever virus: cellular responses also play a role in protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

RNA recombination between persisting pestivirus and a vaccine strain: generation of cytopathogenic virus and induction of lethal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Marker vaccine strategies and candidate CSFV marker vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Development of a live attenuated antigenic marker classical swine fever vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

An experimental marker vaccine and accompanying serological diagnostic test both based on envelope glycoprotein E2 of classical swine fever virus (CSFV).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Classical swine fever virus E2 glycoprotein antigen produced in adenovirally transduced PK-15 cells confers complete protection in pigs upon viral challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Early onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Type I IFN as a vaccine adjuvant for both systemic and mucosal vaccination against influenza virus

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

inferred from DOI database lookup

7 January 2021

based on heuristic

Alpha interferon is a powerful adjuvant for a recombinant protein vaccine against foot-and-mouth disease virus in swine, and an effective stimulus of in vivo immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Adenovirus-mediated expression of interferon-alpha delays viral replication and reduces disease signs in swine challenged with porcine reproductive and respiratory syndrome virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Interferons (IFNs) are key cytokines in both innate and adaptive antiviral immune responses--and viruses counteract IFN action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Viruses and interferon: a fight for supremacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

The mRNA regulation of porcine double-stranded RNA-activated protein kinase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Production of monoclonal antibodies against swine fever virus and their use in laboratory diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Origin and evolution of viruses causing classical swine fever in Cuba.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Thermal stress treatment does not affect the stability and protective capacity of goat milk derived E2-marker vaccine formulation against CSFV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Virus interference. I. The interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

IFN-alpha/beta enhances BCR-dependent B cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Induction of bystander T cell proliferation by viruses and type I interferon in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Type I interferons enhance production of IFN-gamma by NK cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Type I interferons keep activated T cells alive

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Antiviral action of interferon-alpha against porcine transmissible gastroenteritis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Oral treatment of transmissible gastroenteritis with natural human interferon alpha: a field study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Pharmacokinetics of interferon alpha-2b in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.073

10.1016/J.VACCINE.2010.09.073

7 January 2021

Identifiers

DOI

1 reference

13 September 2017

1 reference